ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations.

Eranga R Balasooriya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.